Related Experiment Video
Updated: Nov 17, 2025
10:31
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
436
Euglycemic diabetic ketoacidosis associated with uremia
Mingxia Zhang1, Haiyan Xiang1, Hui Fan1
1Minda Hospital of Hubei Minzu University Enshi China.
Clinical Case Reports
|February 18, 2021
Summary
Diabetic ketoacidosis (DKA) treatment is challenging in patients with uremia due to heart failure risks. Continuous renal replacement therapy offers a superior alternative for managing these complex cases.
Area of Science:
- Nephrology
- Endocrinology
- Critical Care Medicine
Background:
- Diabetic ketoacidosis (DKA) is a serious complication of diabetes mellitus.
- Patients with end-stage renal disease (uremia) present unique challenges for DKA management.
- Comorbidities like heart failure increase risks in DKA patients with uremia.
Observation:
- Standard DKA treatments may be insufficient or contraindicated in patients with uremia.
- Uremic patients often have reduced urine output, complicating fluid management.
- These patients are particularly vulnerable to fluid overload and cardiac complications.
Findings:
- Continuous renal replacement therapy (CRRT) demonstrated efficacy in managing DKA in uremic patients.
- CRRT allows for precise control of fluid balance and electrolyte correction.
- This therapy mitigates risks associated with fluid administration and potential cardiac strain.
Implications:
- CRRT should be considered a primary treatment modality for DKA in patients with uremia.
- Implementing CRRT can improve outcomes and reduce mortality in this high-risk population.
- Further research should explore optimal CRRT protocols for DKA management in renal failure.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
505
07:52A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
21.4K
Related Concept Videos
01:24Chronic Kidney Disease II: Clinical Manifestations
316
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
316
01:15Diabetes: Symptoms, Diagnosis, and Complications
1.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.5K
01:20Inborn Errors of Metabolism
521
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
521
01:25Chronic Kidney Disease I: Introduction
352
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
352
01:28Chronic Kidney Disease III: Interprofessional Care
201
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
201
01:29Acute Kidney Injury III: Clinical Manifestations
423
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
423